Erika J Lampert

4PUBLICATIONS
9CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 13, 2024
Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients.

Erika J Lampert, Jennifer L Hansen, Surabhi Tewari

|Apr 06, 2023
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancer.

Erika J Lampert, Peter G Rose, Meng Yao

|Jul 26, 2020
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses.

Erika J Lampert, Ashley Cimino-Mathews, Joo Sang Lee

|May 14, 2020
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study.

Erika J Lampert, Alexandra Zimmer, Michelle Padget

Pageof 1

Frequent Collaborators

2 joint publications

Ashley Cimino-Mathews

2 joint publications

Meng Yao

1 joint publications

Alexandra Zimmer

1 joint publications

Elizabeth M Swisher